Introduction {#sec1}
============

Macroautophagy, which we will refer to as autophagy, is a highly conserved catabolic process in which cytoplasmic proteins and organelles are engulfed by double-membrane structures called autophagosomes, which are then transported to lysosomes for degradation. Autophagy is a key regulator of many physiological and disease processes and mediates the removal of protein oligomers, mitochondria, and various pathogens. In organisms from yeast to man, autophagy is upregulated in response to nutrient deprivation to allow cells to generate energy-rich compounds from cytoplasmic macromolecules ([@bib28]).

Autophagosomes are formed by the elongation and fusion of cup-shaped structures called phagophores. The biogenesis of mammalian (and yeast) autophagosomes involves two ubiquitin-like proteins, ATG12 and LC3 (ATG8) ([@bib19]). The earlier of the ubiquitination-like events in autophagosome biogenesis involves the conjugation of ATG12 to ATG5, after which ATG12-5 can form a complex with ATG16L1 ([@bib16]). This ATG12-5-16L1 complex decorates prephagophore structures and phagophores but dissociates from completed autophagosomes. The elongation of the edges of the phagophore involves a second ubiquitin-like protein, LC3, an ATG8 family member, which is cleaved by ATG4 to form cytoplasmic LC3-I. Cytoplasmic LC3-I is then covalently conjugated to phosphatidylethanolamine on the phagophore membrane (where it is called LC3-II). LC3-II is specifically associated with phagophore and autophagosome membranes, and the intra-autophagosomal LC3-II is degraded in the lysosome. Thus, LC3-II levels and the numbers of LC3 vesicles correlate with autophagosome numbers ([@bib27]).

The origin of the autophagosome membranes has been a major question in the field, and recent studies suggest that there may be contributions from multiple sources. Under conditions in which autophagy is induced by various forms of starvation, autophagosomes appear to be formed at the endoplasmic reticulum (ER) via structures called omegasomes ([@bib2; @bib8; @bib9; @bib41]) and at mitochondria ([@bib7]). Recently, we showed that plasma membrane contributes to nascent autophagosomes under both basal and autophagy induction conditions ([@bib24]). We found that ATG16L1 associates with clathrin-coated pits, and after internalization and uncoating, the ATG16L1-associated plasma membrane becomes associated with phagophore precursors, which mature into phagophores and then autophagosomes. Inhibition of clathrin-mediated endocytosis causes defective autophagosome formation, which is associated with impaired uptake of plasma membrane into autophagic precursors and autophagosomes ([@bib24]). We recently showed that the small G protein ARF6 also has a function in autophagy and that part of its effects on autophagy could be explained by the fact that it stimulates phosphatidylinositol 4,5-biphosphate (PIP~2~) formation at the plasma membrane. Plasma membrane PIP~2~ regulates endocytosis, and this is likely to explain part of its importance for autophagy ([@bib18]). The ATG16L1-positive phagophore precursors undergo SNARE-mediated homotypic fusion events to give rise to tubulovesicular structures, and the increase in size resulting from these fusions enhances the capacity of these structures to acquire ATG8/LC3, which marks phagophores ([@bib17]).

mATG9 is the only known multipass transmembrane protein that is necessary for optimal autophagy ([@bib20; @bib42]). Because some mATG9 is seen in autophagosomes, its itinerary may provide important clues to additional membrane sources. In yeast and in mammalian cells, mATG9 has been associated with the Golgi apparatus, suggesting that this may provide yet additional membranes for autophagosomes ([@bib35; @bib42]). However, these authors have argued on the basis of their recent data that this model may be overly simplistic because mammalian ATG9 (mATG9 and ATG9L1) was seen to associate with many other compartments, including recycling endosomes, early endosomes, and late endosomes ([@bib20]). Furthermore, mATG9 interactions with omegasomes and autophagosomes have been examined using live-cell imaging and fusion events were not observed, leading to the suggestion that mATG9 undergoes "dynamic" interactions with phagophores and autophagosomes without being incorporated into their membranes and that mATG9 traffics by tubulation from an existing reservoir compartment, analogous to what has been described in yeast ([@bib14; @bib20]). It is therefore still unclear how mATG9 traffics, how it ends up associated with some LC3-positive structures if no obvious fusion events appear to occur, and whether mATG9 vesicles contribute membrane to mammalian autophagosomes. Furthermore, although distinct sources of autophagosome membranes have been proposed, it is not clear to what extent they may be mutually exclusive (possibly regulated via different autophagy signals) or whether they may coalesce and cooperate.

Here, we find that mATG9 vesicles are trafficked from the plasma membrane to the recycling endosome via clathrin-coated pits that are largely distinct from those that endocytose ATG16L1. We found that ATG16L1 was also present in the recycling compartment and participates in vesicle fusions with mATG9-postive vesicles in that site. The fusions between ATG16L1 and mATG9 are enhanced by reducing membrane egress from the recycling endosomes, a perturbation that also increases autophagosome formation. This process, which is dependent on the R-SNARE VAMP3, appears to be physiologically relevant, as starvation, an evolutionarily conserved autophagy stimulus, also reduces membrane exit from the recycling endosomes and results in increased associations of mATG9 and ATG16L1.

Results {#sec2}
=======

mATG9 Is Associated with Recycling Endosomes {#sec2.1}
--------------------------------------------

mATG9 has been reported to be localized at the trans-Golgi network (TGN) but also in recycling endosomes ([@bib20; @bib42]). The recycling endosome is so close to the TGN that it is sometimes difficult to distinguish between the two compartments at the EM level ([@bib22]). The most commonly used marker for recycling endosomes is RAB11, a small GTPase that regulates transferrin recycling through this compartment ([@bib25; @bib29; @bib34]). Consistent with earlier data, we found good colocalization between mATG9 and RAB11 ([Figures 1](#fig1){ref-type="fig"}A′ and A″). Transferrin and its cognate receptor are internalized by clathrin-mediated endocytosis and recycled back to the plasma membrane through early endosomes or transferred to recycling endosomes for recycling back to the plasma membrane via a slower pathway ([@bib15]). At steady state, recycling endosomes are the predominant intracellular site at which one sees the transferrin receptor (TfR), as well as its ligand transferrin. Indeed, mATG9 colocalized well with transferrin at 37°C ([Figure 1](#fig1){ref-type="fig"}B). Likewise, mATG9 also appeared to colocalize with a TGN marker, TGN46 ([Figure 1](#fig1){ref-type="fig"}B).

In order to examine how mATG9 may arrive at recycling endosomes, we initially incubated cells at 18°C because this inhibits membrane traffic between early and recycling endosomes ([@bib25; @bib38]) ([Figures S1](#figs1){ref-type="fig"}A--S1C available online). As expected, the temperature block caused a peripherally biased redistribution of transferrin-positive vesicles, increased transferrin association with the early endosome marker EEA1, and decreased transferrin association with the recycling endosome marker RAB11 ([Figures S1](#figs1){ref-type="fig"}A--S1C and C′). Furthermore, the 18°C incubation led to a peripherally biased dispersion of mATG9 (similar to what we observed with transferrin \[[Figure 1](#fig1){ref-type="fig"}B\]), increased mATG9 colocalization with the early endosome marker EEA1 ([Figures S1](#figs1){ref-type="fig"}D and D′), and reduced its colocalization with TGN46 (a marker for TGN) ([Figure 1](#fig1){ref-type="fig"}B). This suggests that the predominant effects of 18°C on mATG9 localization are not due to failed exit from the Golgi-impaired Golgi-recycling endosome trafficking, which has been described in polarized cells at 18°C ([@bib1; @bib6]). These results raised the possibility that most of the mATG9 that appeared to be at the TGN in basal conditions may actually be in recycling endosomes nearby and that the TGN pool of mATG9 may be quite small. Furthermore, these data suggest that most of the mATG9 in the recycling endosomes comes from the early endosomes/plasma membrane rather than from the TGN. (The decreased transferrin-mATG9 colocalization at 18°C is very likely due to the known reduction of transferrin uptake that occurs at reduced temperature \[[Figure 1](#fig1){ref-type="fig"}B\].)

mATG9 Is Internalized by Clathrin-Mediated Endocytosis {#sec2.2}
------------------------------------------------------

The experiments described above reveal that a pool of mATG9 is trafficking with transferrin. Because transferrin enters the cell by clathrin-mediated endocytosis, we examined whether mATG9 is trafficked to the plasma membrane and then internalized by clathrin-mediated endocytosis. First, we acutely inhibited endocytosis by treating cells with the dynamin inhibitor Dynasore ([@bib32]). Dynasore treatment caused a redistribution of mATG9 from a perinuclear concentration to a more dispersed localization, and this was associated with decreased colocalization of mATG9 with transferrin or a Golgi marker ([Figure 1](#fig1){ref-type="fig"}C). Total internal reflection fluorescence (TIRF) microscopy, which enables high-resolution assessment of molecules close to the plasma membrane, suggested that mATG9 redistributed close to the plasma membrane in Dynasore-treated cells ([Figure 1](#fig1){ref-type="fig"}D). A similar redistribution of mATG9 from its normal perinuclear localization close to the plasma membrane was seen in cells overexpressing a dominant-negative dynamin mutant or small interfering RNA (siRNA) to the clathrin adaptor AP2 (to block clathrin-dependent endocytosis) ([Figures 1](#fig1){ref-type="fig"}D and [S1](#figs1){ref-type="fig"}E--S1G). The presence of mATG9 on the plasma membrane was confirmed by cell surface biotinylation, followed by immunoprecipitation ([Figure 1](#fig1){ref-type="fig"}E). Moreover, electron microscopy (EM) analysis showed mATG9 on clathrin-coated structures on the plasma membrane ([Figures 1](#fig1){ref-type="fig"}Fa--1Fc). As a control, we showed that almost no clathrin labeling was observed in cells transfected and labeled with GFP ([Figure S1](#figs1){ref-type="fig"}H). In addition to clathrin-coated structures, EM also revealed mATG9 associated with plasma membrane, endocytic structures, autophagic structures, and Golgi ([Figure S1](#figs1){ref-type="fig"}I).

ATG16L1 and mATG9 Are Not Internalized by the Same Clathrin-Coated Structures {#sec2.3}
-----------------------------------------------------------------------------

Because both ATG16L1 ([@bib24]) and mATG9 are associated with clathrin-coated pits, we wondered whether they were in the same structures and followed the same internalization routes. To address this question, we transfected HeLa cells with GFP-ATG16L1, fixed, labeled for endogenous mATG9, and analyzed by TIRF microscopy, which assesses structures within 200 nm of the plasma membrane ([Figures 1](#fig1){ref-type="fig"}G and [S1](#figs1){ref-type="fig"}J). Note that clathrin-coated structures on the plasma membrane are 100--150 nm in diameter ([@bib31]). In the same experiment, control cells were cotransfected with mStrawberry-ATG16L1 and GFP-ATG16L1. This experiment revealed that the mATG9 and ATG16L1 signals were almost completely distinct. The control experiment showed almost complete overlap of the mStrawberry-ATG16L1 and GFP-ATG16L1 ([Figures 1](#fig1){ref-type="fig"}G and [S1](#figs1){ref-type="fig"}J). In order to analyze the clathrin-coated structures carrying these two proteins with greater resolution, we treated cells with Dynasore to recruit as much as possible ATG16L1 and mATG9 to the plasma membrane and then performed immunogold labeling on cryosections to observe the two proteins. Remarkably, at the EM level, mATG9 and ATG16L1 appeared to associate with two different pools of clathrin-coated structures ([Figures 1](#fig1){ref-type="fig"}H--1J). mATG9 and ATG16L1 appear to be internalized via different routes because mATG9 was associated with EEA1-positive early endosomes, whereas ATG16L1 was not seen with EEA1 (consistent with what we have reported previously \[[@bib17; @bib24]\]) ([Figure S1](#figs1){ref-type="fig"}K). We confirmed this observation using the RAB5 constitutive-active mutant Q79L, which induces aberrant fusion of early endosomes ([@bib30]) and has been used widely to enable better resolution of proteins associated with early endosomes. This RAB5 mutant colocalizes only with mATG9 and not with ATG16L1 ([Figure S1](#figs1){ref-type="fig"}L).

ATG16L1 Vesicles Are Seen in the RAB11 Compartment {#sec2.4}
--------------------------------------------------

Because mATG9 vesicles appear to arrive at recycling endosomes via endocytosis, we investigated whether ATG16L1 vesicles also localized to that compartment. We performed EM studies to identify possible intracellular sites associated with ATG16L1 and observed ATG16L1-positive tubulovesicular structures (probably phagophore precursors) localizing close to the Golgi ([Figure 2](#fig2){ref-type="fig"}A). These ATG16L1-positive structures are associated with endocytosed cholera toxin ([Figure 2](#fig2){ref-type="fig"}A), which binds to the plasma membrane and traffics to recycling endosomes and the Golgi ([@bib3; @bib24]). Because the ATG16L1 tubulovesicular structures appear to be distinct from the Golgi, we tested whether ATG16L1 trafficked through recycling endosomes. ATG16L1 colocalized with RAB11 ([Figures 2](#fig2){ref-type="fig"}B--2D). EM analysis showed that ATG16L1 and RAB11 localized in the same tubulovesicular structures ([Figure 2](#fig2){ref-type="fig"}C). We have used very low levels of overexpressed ATG16L1 to avoid artifacts ([@bib24]) but to enable efficient visualization of those vesicles.

We have previously shown that low levels of exogenous ATG16L1 decorate early autophagic structures and colocalize with ATG5 and ATG12 ([@bib17; @bib24]). Indeed, ATG12 also colocalized with RAB11 ([Figure S2](#figs2){ref-type="fig"}A).

Homotypic fusion of ATG16L1 vesicles is an important step that increases the size of these structures and facilitates their progression to the phagophore stage ([@bib17]). Accordingly, we tested whether homotypic fusions of ATG16L1 vesicles associated with the RAB11 compartment. Interestingly, live-imaging analysis of ATG16L1 and RAB11 confirmed that such homotypic fusions occurred, and there also appeared to be progressive recruitment of RAB11 (vesicles from recycling endosomes) to the ATG16L1 (preautophagosome) vesicles ([Figure 2](#fig2){ref-type="fig"}D and [Movie S1](#mmc1){ref-type="supplementary-material"}), suggesting that the recycling compartment may provide membranes to preautophagosomal structures.

ATG16L1 Colocalizes with mATG9 in Recycling Endosome Compartment {#sec2.5}
----------------------------------------------------------------

Because ATG16L1 and mATG9 are both localized to recycling endosomes, we tested and confirmed that they colocalize together with RAB11 ([Figure S2](#figs2){ref-type="fig"}B). This was consistent with EM data showing colocalization of ATG16L1 and mATG9 on structures that are associated with the transferrin receptor ([Figure 2](#fig2){ref-type="fig"}E). Importantly, this colocalization is occurring prior to the phagophore stage because such colocalizations appear in some vesicles that are LC3 negative ([Figure 2](#fig2){ref-type="fig"}F). Although previous studies have failed to see proper fusions between mATG9-containing vesicles and autophagosome-related structures, these did not study ATG16L1 phagophore precursors ([@bib20]). However, we observed authentic and long-lasting fusions between mATG9 and ATG16L1-positive structures, suggesting that mATG9 vesicles and associated membranes mix with ATG16L1-positive phagophore precursors and that mATG9 becomes associated with autophagosome precursors at this early prephagophore stage ([Figure 2](#fig2){ref-type="fig"}G and [Movie S2](#mmc2){ref-type="supplementary-material"}). The colocalization of mATG9 and ATG16L1 in the recycling endosomes raised the possibility that these fusion events may be occurring in that compartment.

Temperature Block Inhibits mATG9-ATG16L1 Vesicle Fusion and Autophagosome Formation {#sec2.6}
-----------------------------------------------------------------------------------

Our data suggest that the recycling endosome is the site of fusion between mATG9 and ATG16L1 vesicles and led us to hypothesize that membrane flow in and out of the recycling compartment may influence mATG9-ATG16L1 fusions and autophagy. Accordingly, we initially studied the effect of reducing the temperature to 18°C because this inhibits membrane traffic between early and recycling endosomes ([@bib25; @bib38]). The most common method used to study autophagy is to assay LC3-II levels, which correlates with autophagosome numbers. LC3-II changes can result from altered autophagosome formation and/or degradation. These possibilities can be deconvoluted by studying cells in the absence and presence of lysosomal inhibitors like Bafilomycin A~1~ or NH~4~Cl, which inhibit autophagosome degradation and hence allow one to assess autophagosome formation rates ([@bib27]). The temperature block (18°C) that inhibits membrane traffic between early and recycling endosomes ([@bib25; @bib38]) ([Figures S1](#figs1){ref-type="fig"}A--S1C) and which causes endocytosed transferrin to accumulate mostly in early endosomes ([Figures S1](#figs1){ref-type="fig"}B and S1C) also clearly impairs autophagosome formation as measured on LC3-II blots ([Figures 3](#fig3){ref-type="fig"}A--3C). Cells incubated at 18°C also had more numerous but smaller ATG16L1 vesicles ([Figures 3](#fig3){ref-type="fig"}D and 3E)---which is compatible with decreased efficiency and/or frequency of ATG16L1 vesicle homotypic fusion events ([@bib17])---and caused accumulation of ATG16L1 in recycling endosomes but did not lead to a change in its negligible abundance in early endosomes (note that the low level of colocalization we see may be "background" due to labeling of adjacent structures) ([Figures 3](#fig3){ref-type="fig"}F and 3G). In addition, the temperature block decreased the extent to which ATG16L1 and mATG9 colocalized and decreased the sizes of both mATG9 and ATG16L1 vesicles ([Figures 3](#fig3){ref-type="fig"}H and [S3](#figs3){ref-type="fig"}A for separate channels), suggesting that this treatment impaired homotypic and heterotypic fusion of ATG16L1 and mATG9 vesicles.

Because decreased temperature has diverse effects, one cannot draw very strong conclusions that the 18°C effects are specifically due to decreased membrane flow into the recycling compartment. Accordingly, we aimed to test the converse situation by reducing membrane egress from the recycling compartment by overexpressing RAB11 ([@bib25]) or by inhibiting Myosin Vb by overexpressing its tail domain ([@bib11]). Both RAB11 and Myosin Vb tail overexpression enhanced autophagosome formation (LC3-II levels in the presence or absence of Bafilomcyin A~1~) ([Figure 3](#fig3){ref-type="fig"}I). Autophagy regulates the proportion of cells with mutant huntingtin Q74 (HTT) aggregates by regulating mutant HTT clearance, and the percentage of cells with aggregates correlates inversely with autophagic activity ([@bib13; @bib23]). The proportion of cells with mutant HTT aggregates was reduced in cells transfected with RAB11 or the Myosin Vb tail ([Figure S3](#figs3){ref-type="fig"}B). Overexpression of RAB11 and Myosin Vb tail also increased the size of ATG16L1 vesicles ([Figures 3](#fig3){ref-type="fig"}J and [S3](#figs3){ref-type="fig"}C) (consistent with increased homotypic fusion of ATG16L1 vesicles), increased the colocalization of ATG16L1 with the transferrin ([Figures 3](#fig3){ref-type="fig"}K and [S3](#figs3){ref-type="fig"}D) (consistent with more ATG16L1 in the recycling compartment), and increased the colocalization of ATG16L1 and mATG9 ([Figures 3](#fig3){ref-type="fig"}L and [S3](#figs3){ref-type="fig"}E) (consistent with enhanced heterotypic fusion of mATG9 and ATG16L vesicles). Furthermore, homotypic ATG16L1 interactions were also enhanced in real time when the cells overexpressed RAB11 or the Myosin Vb tail ([Figures S3](#figs3){ref-type="fig"}F and S3G).

Starvation Decreases Recycling and Increases ATG16L1 and mATG9 Colocalization {#sec2.7}
-----------------------------------------------------------------------------

We examined the links between autophagy induction, recycling endosomes, homotypic ATG16L1 fusion, and heterotypic ATG16L1-mATG9 fusion during starvation, an evolutionarily conserved autophagic stimulus. Amino acid and serum starvation decreased transferrin recycling, similar to what is observed with RAB11 or Myosin Vb tail overexpression ([@bib11; @bib25; @bib38]) ([Figure S3](#figs3){ref-type="fig"}H). Again, similar to RAB11 or Myosin Vb tail overexpression, starvation increased ATG16L1 vesicle interactions in real time, consistent with what we reported previously ([@bib17]) ([Figure S3](#figs3){ref-type="fig"}I and [Movies S3](#mmc3){ref-type="supplementary-material"} and [S4](#mmc4){ref-type="supplementary-material"}). Likewise, starvation increased the colocalization of ATG16L1 with transferrin ([Figure 3](#fig3){ref-type="fig"}M) and increased the colocalization of ATG16L1 with mATG9 ([Figure 3](#fig3){ref-type="fig"}N).

VAMP3 Mediates ATG16L1-mATG9 Fusion {#sec2.8}
-----------------------------------

These data suggest that mATG9 vesicles likely travel from early endosomes to recycling endosomes where they meet ATG16L1-containing vesicles, which arrive at recycling endosomes via a route that does not appear to involve a significant residence time in early endosomes. The fusion of these vesicles appears to be rate limiting for autophagosome formation. In order to clarify the itineraries of these vesicles and their trafficking routes more robustly, we needed to identify further molecular regulators of their fusion. Because intracellular vesicular fusions are generally SNARE dependent, we tested and confirmed that this was the case for ATG16L1-mATG9 fusions because *N*-ethylmaleimide (NEM), which abolishes SNARE fusion ([@bib10; @bib17; @bib5]), reduced the colocalization in cells between ATG16L1 and mATG9 ([Figure 4](#fig4){ref-type="fig"}A) and impaired the fusion of these two vesicle populations in vitro using postnuclear supernatants isolated from either Strawberry-ATG16L1- or ATG9L1-GFP-expressing cells ([Figures 4](#fig4){ref-type="fig"}B--4D). Typically, SNARE complexes comprise three molecules with highly conserved glutamine (Q) residues in the SNARE motif and one with a highly conserved arginine (R) residue in this domain, namely Qa-, Qb-, Qc-, and R-SNAREs ([@bib10]). In order to identify such SNAREs pertinent to ATG16L1 and mATG9 vesicle fusion, we started screening for the levels of the autophagy substrate p62 ([@bib26]) in cells where different R-SNAREs were knocked down with siRNAs. VAMP3 knockdown resulted in the strongest elevation of p62 levels ([Figure 5](#fig5){ref-type="fig"}A). We confirmed that VAMP3 indeed regulated autophagy by showing that it decreased autophagosome numbers (LC3-II levels on western blots versus actin and a 60% reduction in the number of LC3-positive vesicles \[autophagosomes\]), which could be accounted for by impaired autophagosome biogenesis (LC3-II levels in the presence of Bafilomycin A~1~) ([Figures 5](#fig5){ref-type="fig"}B, 5C, [S4](#figs4){ref-type="fig"}A, and S4B).

VAMP3 localizes in early endosomes (EEA1 positive) and recycling endosomes (RAB11 positive) ([Figure 5](#fig5){ref-type="fig"}D), as described previously ([@bib40; @bib21]), suggesting that it was in appropriate compartments for regulating mATG9-ATG16L1 vesicle fusions. A temperature block at 18°C, which impairs trafficking between early and recycling endosomes, did not affect the colocalization between mATG9 and VAMP3, suggesting that the two proteins are cotrafficking ([Figure 5](#fig5){ref-type="fig"}E), but reduced the colocalization between ATG16L1 and VAMP3 ([Figures 5](#fig5){ref-type="fig"}E and [S4](#figs4){ref-type="fig"}C) in a manner reminiscent to what we observed with mATG9 and ATG16L1 ([Figure 3](#fig3){ref-type="fig"}H). These data strengthen the likelihood of a connection between VAMP3 and mATG9-ATG16L1 and support the hypothesis that VAMP3 is trafficking with mATG9 from early endosomes to recycling endosomes where ATG16L1 localizes.

VAMP3 knockdown did not affect the morphology of the recycling endosomes (marked by RAB11) ([@bib25]) or the endocytosis of transferrin ([Figures S4](#figs4){ref-type="fig"}D and S4E), suggesting that it did not grossly affect endocytic trafficking.

However, VAMP3 knockdown caused the accumulation of mATG9 in early endosomes (EE) and reduced its localization in recycling endosomes (RE) ([Figures 6](#fig6){ref-type="fig"}A--6C). In contrast to what we observed with mATG9, knockdown of VAMP3 caused the accumulation of ATG16L1 in recycling endosomes but did not lead to a change in its negligible abundance in early endosomes (note that the low level of colocalization we see may be "background" due to labeling of adjacent structures) ([Figures 6](#fig6){ref-type="fig"}D--6F). VAMP3 knockdown reduced the colocalization of mATG9 and ATG16L1 ([Figure 7](#fig7){ref-type="fig"}A), and live-cell imaging demonstrated that coalescence between ATG16L1 and mATG9 was abrogated by VAMP3 knockdown as compared to control cells ([Figures S5](#figs5){ref-type="fig"}A and S5B; see also [Movies S5](#mmc5){ref-type="supplementary-material"} and [S6](#mmc6){ref-type="supplementary-material"}) without affecting homotypic fusion of ATG16L1 vesicles ([Figure 7](#fig7){ref-type="fig"}B). Consistent with these data, VAMP3 knockdown impaired in vitro fusion of ATG16L1 and mATG9 vesicles (vesicles probably derived from recycling and early endosomes, respectively) ([Figure 7](#fig7){ref-type="fig"}C).

Discussion {#sec3}
==========

Previous studies have shown that loss of mATG9 compromises mammalian autophagy, suggesting that this protein is a critical part of the autophagy apparatus ([@bib20]). Its role in autophagy has, however, been elusive. As the only known multipass transmembrane ATG protein, it has been assumed that it may play a role in lipid delivery to nascent autophagosomes. However, despite having some colocalization with LC3-positive structures, mATG9 was previously found to have less colocalization with autophagic markers than with other organelles ([@bib12; @bib20]). This observation could be interpreted as suggesting that mATG9 has a complex itinerary and that it fuses with autophagosomes at some stage of their biogenesis. However, based on studies examining LC3- or DFCP1-positive structures, mATG9 did not seem to fuse with these structures but instead circled around them, leaving the question open whether mATG9 contributed membrane to autophagosomes or whether it had some other activities.

Our data suggest that mATG9 does indeed follow a complex itinerary and also becomes associated with nascent autophagosomes. Because mATG9 is a transmembrane protein, it is likely that it is incorporated into autophagosomes precursors with some membrane from its originating compartment. Previously, we showed that the plasma membrane is important for autophagosome biogenesis by contributing membrane to ATG16L1-positive phagophore precursors ([@bib17; @bib24]). Interestingly, we found very low levels of colocalization between ATG16L1 and EEA1, suggesting that the ATG16L1 vesicles were routed away from early endosomes soon after clathrin uncoating ([@bib17; @bib24]). Here, we have found that mATG9 also traffics via the plasma membrane. In this case, mATG9 appears to be localized to a largely distinct pool of clathrin pits compared to ATG16L1, and although both proteins end up in recycling endosomes, mATG9 is trafficked to recycling endosomes via EEA1-positive early endosomes, whereas ATG16L1 has minimal residence in early endosomes (supported by both temperature block and VAMP3 knockdown experiments). The observation that mATG9 and ATG16L1 are trafficking via distinct routes is entirely consistent with the idea that they are internalized via largely distinct clathrin coats. There is a precedent for this type of process because it has been previously shown that different plasma membrane receptors are frequently endocytosed via different clathrin-coated structures ([@bib33; @bib36; @bib37; @bib39]).

It is likely that some plasma membrane mATG9 ends up being trafficked from early to recycling endosomes for fusion with ATG16L1. Although we cannot exclude other sources for early endosomal mATG9, our temperature block experiments suggest that mATG9 in early endosomes is not predominantly derived from the Golgi, as this protein accumulates in early endosomes rather than the Golgi at 18°C.

Our data suggest that the recycling endosome is where true fusions occur between distinct ATG16L1 and mATG9-positive structures. The fusion event occurs at the prephagophore stage, as it involves ATG16L1-positive, LC3-negative vesicles. The coalescence of mATG9 and ATG16L1 depends on SNARE function, and we have identified VAMP3 as one of the critical mediators. The mATG9-ATG16L1 fusions are distinct from the homotypic ATG16L1 fusions, as the former, but not the latter, requires VAMP3. VAMP3 appears to colocalize first with mATG9 in early endosomes ([Figure 5](#fig5){ref-type="fig"}E) and then likely fuses with partner SNAREs on ATG16L1 in recycling endosome-associated structures, resulting in colocalization with both proteins. This model is consistent with our observations with the 18°C temperature block, which inhibits membrane trafficking between early and recycling endosomes ([@bib25; @bib38]), as this treatment decreased the association of VAMP3 with ATG16L1 ([Figures 5](#fig5){ref-type="fig"}E and [S4](#figs4){ref-type="fig"}C), but not with mATG9 ([Figure 5](#fig5){ref-type="fig"}E), and impaired the colocalization between ATG16L1 and mATG9 ([Figure 3](#fig3){ref-type="fig"}H).

Although VAMP3 has previously been linked to autophagy, it is important to clarify that [@bib4] suggested that VAMP3 is involved in a much later stage of the pathway---the fusion of already-completed autophagosomes with multivesicular bodies to form amphisomes. This is not the stage of autophagosome biogenesis we are concerned with---we are describing the processes and structures preceding the formation of LC3-positive autophagosomes. It is also worth noting that [@bib4] do not formally demonstrate that VAMP3 is the relevant SNARE, as they use tetanus toxin for their experiments, and this toxin inactivates many SNAREs.

Our data reveal that membrane traffic from early to recycling endosomes is crucial for autophagosome formation and that the recycling compartment is not merely responsible for recycling of plasma membrane receptors but also serves as a station in the early stages of autophagosome biogenesis where mATG9 and ATG16L1 meet. The observation that VAMP3 knockdown has no obvious effect on transferrin recycling (compared to the dramatic consequences of the 18°C temperature block) suggests either that the fusion of the mATG9 and ATG16L1 compartments may have a higher dependency on this R-SNARE than conventional endocytic trafficking or that VAMP3 may be mediating selective fusion of components of the early endosomal and recycling endosome compartments rather than "bulk" fusion. The relevant partner, Q-SNAREs, regulating this event will need to be elucidated in future studies (and may be difficult to pinpoint because some SNAREs participate in multiple distinct fusion events as a function of their partners \[[@bib10]\]). However, the identification of VAMP3 allowed us to propose that the coalescence between ATG16L1 and mATG9 in recycling endosomes mediated by VAMP3 is likely a critical event required for autophagy because VAMP3 knockdown also decreased autophagosome formation ([Figure 7](#fig7){ref-type="fig"}D). It is tempting to speculate that the VAMP3-mediated fusion of the ATG16L1 and mATG9 compartments may also be important for exit of preautophagosomal structures containing these proteins from recycling endosomes, as ATG16L1 accumulated in these structures when VAMP3 was knocked down ([Figures 6](#fig6){ref-type="fig"}D and 6E). This model suggests that ATG16L1-containing vesicles may require VAMP3/mATG9 fusion in order to be competent to exit the recycling endosomes and mature into phagophores ([Figure 7](#fig7){ref-type="fig"}D). Our data do not exclude additional sources for autophagosome membrane, and our demonstration that mATG9 and ATG16L1 meet prior to acquisition of LC3 suggests the likelihood that multiple independent membrane sources and itineraries may contribute to autophagosomes. Indeed, an important challenge for future work will be to define the distinct compartments that may contribute to autophagosome biogenesis and understand how their fusions are regulated. It is possible that such fusion events may occur in diverse cellular locations, depending on which components are examined.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Sigma D6548) supplemented with 2 mM L-glutamine, 100 U/ml penicillin/streptomycin, and 10% fetal bovine serum in 5% CO~2~ at 37°C.

Western Blot Analysis and Modulation of Autophagy {#sec4.2}
-------------------------------------------------

Cells were treated with Bafilomycin A~1~ (400 nM for 4 hr or 200 nM for 16 hr) or with NH~4~Cl (20 mM for 16 hr) or not treated and then lysed in Laemmli buffer. Protein samples were boiled 5--7 min at 100°C, separated by SDS-PAGE, transferred onto PVDF membranes, subjected to western blot analysis, and, finally, visualized using an ECL detection kit (GE Healthcare).

Live Imaging {#sec4.3}
------------

HeLa cells were seeded on MatTek Petri dish (MatTek) at a density of ∼1.5 × 10^5^ cells per dish. Cells were placed in HBSS (Ca^+^ Mg^+^) with HEPES, after which they were imaged immediately at 37°C. Five movies of 5 min were recorded for each experiment. Imaging was performed on a Zeiss Axiovert 200 M microscope with a LSM 710 confocal attachment using a 63 × 1.4 NA Plan Apochromat oil-immersion lens.

In Vitro Fusion Assay of ATG16L1 and mATG9 Vesicles {#sec4.4}
---------------------------------------------------

The assay was performed as described with some modifications ([@bib17]). Briefly, two postnuclear supernatants (PNS) from HeLa cells expressing either mStrawberry-ATG16L1 or ATG9L1-GFP were mixed for 60 min in the presence of an ATP regenerative system at 37°C (a control sample was left on ice). After the reaction, the samples were fixed with 2% paraformaldehyde in PBS for 15 min, centrifuged to remove the fixative (13,000 rpm, 5 min), resuspended in distilled water, and mounted with Mowiol 4-88 with DAPI on glass coverslips for confocal observation. The DAPI staining was used to identify the right focus on the coverslip.

Statistics {#sec4.5}
----------

Significance levels for comparisons between two groups were determined with two-tailed t test. ^∗^p ≤ 0.05; ^∗∗^p ≤ 0.01; ^∗∗∗^p ≤ 0.001.

Extended Experimental ProceduresAntibodies and ReagentsThe antibodies used include: rabbit anti-RAB11 (Invitrogen-715300), rabbit anti-ATG16L1 (CosmoBio Co. LTP- TMD-PH-ATG16L; Cell Signaling: 8089S), ATG12 (Cell Signaling: 2010S), mouse anti-tubulin (SIGMA), rabbit anti-LC3 for Western blotting (Novus biological- NB100-2220), mouse anti-HA (Covance MMS-10I), rabbit anti-ATG9 (ABCAM-Ab108338 and SIGMA-A0732), sheep anti-TGN46 (AbD Serotec AH-P500), mouse anti-human Transferrin Receptor (ATCC-5E9C11), human transferrin Alexa-555, Alexa-647 and Alexa-488 (Invitrogen), mouse anti-EEA1 (ABCAM-ab70521), rabbit anti-Clathrin (ABCAM- ab21679), Cholera toxin HRP (Invitrogen), mouse anti-AP2 μ2 (BD AP-50) and anti-HRP (Sigma-P7899), rabbit anti-VAMP3 was a kind gift from A.A. Peden. All the Alexa-conjugated secondary antibodies are from INVITROGEN. Protein-A gold is from CMC (Utrecht- NL).Bafilomycin A~1~ and Dynasore are from SIGMA.PlasmidspmStrawberry-ATG16L1, pEGFP-ATG16L1 and httQ74-HA have been described elsewhere ([@bib43; @bib47]). ATG9L1-pEGFP was a kind gift from Dr Y. Takahashi, VAMP3-HA was a kind gift from Dr. A.A. Peden and pEGFP-LC3 was a kind gift from Tamotsu Yoshimori, pEGFP-MVb tail was a kind gift from Dr. J.A. Mercer and Dynamin K44A pCDNA was a kind gift from Dr. B. Beaumelle.RAB11 was cloned in pEGFP and mCherry C1 into the Xho BamH1 sites. The constructs were validated by sequencing.Cell TransfectionThe cells were seeded at 1-2 x10^5^ per 6-well and transfections were performed using LipofectAMINE 2000 for siRNA and Myrus Bio *Trans*IT -2020, according to the manufacturer's instructions, using 80 nM siRNA (AP2 μ2 siRNA custom oligos that we used previously in [@bib24]) and were compared with control siRNA. ATG16L1-pEGFP and ATG16L1-mStrawberry were transfected in a concentration of 0.3μg per well, httQ74-HA at 0.5 μg and the other constructs at 1μg.VAMP3 was silenced using oligo A (GGCAGGCGCUUCUCAAUUU) or alternatively oligo B (GGAUUACUGUUUCUGGUUAU) and C (GAGUUAACGUGGACAAGGU). All the SMARTpool oligos for the screening were from Dharmacon.Aggregate QuantificationThe httQ74-HA aggregation was detected by immunofluorescence (primary HA antibody). The proportion of transfected cells with aggregates was scored (approx. 500 cells per coverslip). Experiments were performed blinded and in triplicate in at least three independent experiments. Statistics for aggregation assays were calculated as odds ratios (the ratio of cells containing aggregates in each condition).Immunofluorescence MicroscopyHeLa cells were grown on coverslips at confluency of 25% were fixed in 4% paraformaldehyde for 5 min and then permeabilized with 0.1% Triton. 1% BSA in PBS was used for blocking and primary and secondary antibodies. A Zeiss LSM710 confocal microscope was used for fluorescent confocal analysis. All confocal images were taken with a 63 × oil-immersion lens. ImageJ (size and number of vesicles analysis) and Volocity software (PerkinElmer) (colocalization analysis using Pearson's Coefficient or Manders' Coefficient) were used for further analysis and processing of confocal images. The Pearson's Coefficient was used to measure the correlation between the signals from two different markers/proteins. The Manders' Coefficient was used to quantify the localization of protein A in compartment B under different conditions. A minimum of 20 cells were examined each condition. All experiments have been repeated at least three times. The background was fixed for all within-experiment analyses (for Mander's).TIRF and Dynasore TreatmentHeLa cells were treated with Dynasore 100 μM for 2 hr in serum-free medium, or transfected for 16h with Dynamin K44A mutant or AP2 siRNA KD (5^th^ day of treatment) fixed and labeled with anti-ATG9 antibody.The samples were analyzed by total internal reflection fluorescence (TIRF) microscopy (TIRF 3, Carl Zeiss MicroImaging Inc.).Immunogold Electron MicroscopyHeLa cells were transfected with GFP-ATG16L1 for 24h. The cells were starved 1h in HBSS, loaded with anti-TfR antibody (5E9D11) for 1h and then fixed with a mixture of 2% paraformaldehyde and 1% acrolein in phosphate buffer (pH. 7.4) for 2h, at room temperature. Cells were then prepared for ultrathin cryosectioning and immunogold-labeled, as previously described ([@bib45; @bib48]). Briefly, fixed cells were washed once in PBS/0.02 M glycine, after which cells were scraped in 12% gelatin in PBS and embedded in the same solution. The cell-gelatin was cut into 1 mm blocks, infiltrated with 15% PVP in 1.7 M sucrose at 4°C overnight, mounted on aluminum pins and frozen in liquid nitrogen. Ultrathin cryosections were picked up in a mixture of 50% sucrose and 50% methylcellulose and incubated with primary antibodies (ATG16L1, ATG9 and rabbit anti-mouse to recognize TfR) followed by protein A gold (Utrecht). Double and triple labeling was performed as previously described ([@bib46; @bib48]).We optimized double and triple labeling as follows. Briefly, we first performed the three separate single labelings to assess the specificity and the localization of the three different proteins (Clathrin, mATG9 and ATG16L1). Then we performed three sets of double labeling (mATG9/Cla, ATG16L1/Cla, mATG9/ATG16L1) and the opposite sequential combinations (Cla/mATG9, Cla/ATG16L1, ATG16L1/mATG9). This helps us determine the correct sequential order for the antibody labeling. The protein with more abundant labeling is used first (with gold 5nm), which in our case is clathrin. We discovered from the double immunolabeling that mATG9 is the weakest antibody and thus we labeled this last (as the antibody and the gold tend to detach during the multiple immunolabeling procedures). Thus, we decided on the order Clathrin 5nm/ATG16 10 nm/ ATG9 15 nm. The protein A gold is always used from the smallest size to the largest. After each labeling step, the reaction was fixed 5 min with 1% glutaraldehyde in PBS to quench the free antibodies and stabilize the reaction. Of course, with these multiple steps one acquires data with single as well as double labeling and one can monitor for any possible labeling abnormalities that may occur with the sequential process. As an example, we now show single, double and triple labeling in [Figures 1](#fig1){ref-type="fig"}F, 1H, and 1I, respectively.Morphometric analysis was performed directly on the pictures by counting the tubulo-vesicular structures carrying both markers (ATG16L1 and RAB11), compared with the total ATG16L1-labeled structures ([Figure 2](#fig2){ref-type="fig"}C).FACS-Based Endocytosis AssaysTransferrin-recycling assay was performed as previously described ([@bib44]). Briefly, the cells were incubated for 30 min at 37°C in the continuous presence of Tf--Alexa-Fluor-647. Cells were then washed and incubated at 37°C in media supplemented with 100 μg/ml unlabeled transferrin for various times before fixation in 4% paraformaldehyde in PBS. Cell-associated Tf--Alexa-Fluor-647 was determined by FACS analysis using BD FACSCalibur flow cytometer (BD Biosciences) and FlowJo software (Tree Star Inc.).Biotinylation of Cell Surface ProteinsHeLa cells grown on 6-well plates were rinsed twice with ice-cold PBS^2+^ (containing 1 mM MgCl~2~ and 0.1 mM CaCl~2~). Cells were subsequently incubated with freshly prepared ice-cold NHS-LC-Biotin (Pierce) solution (1 mg/ml in ice-cold PBS, 1 mM MgCl~2~, 2 mM CaCl~2~, 150 mM NaCl) for 60 - 90 min at 4°C with gentle agitation. Unreacted NHS-LC-Biotin was then quenched by washing the cells twice with ice-cold quenching buffer (PBS, 1 mM MgCl~2~, 0.1 mM CaCl~2~, 100 mM glycine) for 20 min at 4°C. After quenching, cells were rinsed twice with ice-cold PBS++ and were scraped in RIPA buffer \[50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.5% Sodium Deoxycholate, 0.1% SDS and supplemented with phosphatase and protease inhibitor cocktails\]. After 30 min on ice and occasional brief vortexing, lysates were cleared by centrifugation at 16 000 g for 10 min at 4°C. Samples were then transferred to new tubes containing 40 μl of streptavidin-agarose beads (Pierce). After 2 hr of incubation at 4°C under agitation, the beads were washed three times with RIPA buffer and one time with PBS. The final pellets were resuspended in 40 μl of 2 × Laemmli buffer and denatured at 100°C for 5 min. The beads were pelleted and the solubilized proteins were separated by SDS-PAGE, which was silver stained or transferred onto PVDF membranes and probed with antibodies against ATG9 (ABCAM). Nonspecific binding of unlabeled proteins was assessed by including a control condition in which the biotinylation buffer did not contain biotin.
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![mATG9 Is Internalized by Clathrin-Mediated Endocytosis\
(A′) HeLa cells transfected with pEGFP-RAB11 were fixed in basal conditions and stained for mATG9. Pearson's coefficient: 0.452 ± 0.034 (SEM).\
(A″) HeLa cells were transfected with ATG9L1-pEGFP, fixed in basal condition, and labeled for RAB11. Pearson's coefficient: 0.413 ± 0.020 (SEM).\
(B) HeLa cells were incubated for 1 hr at 37°C or 18°C to reach the correct temperature, loaded with transferrin Alexa-555 for 1 hr, fixed, and labeled with anti-ATG9 and anti-TGN46 (marker for Trans Golgi Network). Histogram shows Pearson's coefficient between ATG9 and transferrin (Tf) or TGN46. Error bar, SEM. ^∗∗∗^p \< 0.001. Inserts show merge at higher magnification.\
(C) HeLa cells were incubated in serum-free medium containing Dynasore 100 μM or DMSO for 2 hr and loaded for 30 min with transferrin Alexa-555. Cells were then fixed and labeled for mATG9 and TGN46. Pearson's coefficient between mATG9 and transferrin or TGN46 was quantified. Error bar, SEM. ^∗∗∗^p \< 0.001. Inserts show the merge at higher magnification.\
(D) Cells treated or not treated with Dynasore or transfected with Dynamin K44A mutant or AP2 siRNA were fixed and then analyzed by TIRF microscopy. Pictures are at the same magnification and brightness. Cells transfected with Dynamin mutant were identified by abnormal transferrin accumulation at the plasma membrane.\
(E) HeLa cells were incubated for 1 hr at 4°C with ice-cold NHS-LC-Biotin (Pierce) solution, rinsed, and lysed in RIPA buffer. Biotinylated proteins were precipitated using streptavidin-agarose beads (Pierce) and blotted for mATG9 to assess protein localization at the plasma membrane.\
(F) HeLa cells treated as in (C) were processed for immunogold labeling on cryosections and stained with anti-mATG9 antibody. Arrows show clathrin-coated structures. Scale bar in a and c, 150 nm; scale bar in b, 100 nm.\
(G) HeLa cells transfected with GFP-ATG16L1 were fixed, labeled for mATG9, and then analyzed by TIRF microscopy. Control cells were cotransfected with GFP-ATG16L1 and Straw-ATG16L1. Pictures are at the same magnification and brightness. See [Figure S1](#figs1){ref-type="fig"}J for quantification.\
(H) HeLa cells treated with Dynasore were processed for immunogold labeling on cryosections and double labeled with ATG16L1 (10 nm) and mATG9 (15 nm). Scale bar, 100 nm.\
(I) HeLa cells treated as in (H) were processed for triple labeling on cryosections (clathrin, 5 nm; ATG16L1, 10 nm; and mATG9, 15 nm). Scale bar, 150 nm.\
(J) Table shows quantification of numbers of clathrin-coated structures carrying mATG9 and ATG16L1 alone or together or neither protein. A minimum of 50 clathrin-coated structures were examined from three different experiments. We constructed a 2 × 2 table with 0 or 1--3 gold particles for mATG9 or ATG16L1 for a X^2^ test to avoid statistical cells with 0 counts. X^2^ = 10.4, df = 1, and p = 0.001.\
See also [Figure S1](#figs1){ref-type="fig"}.](gr1){#fig1}

![ATG16L1 Is Found in Recycling Endosomes\
(A) HeLa cells transfected with GFP-ATG16L1 for 24 hr were incubated for 15 min with 2.5 μg/ml with HRP-cholera toxin subunit B at 4°C and then for 10 min at 37°C. Cells were then fixed and treated for immunogold labeling on cryosections. ATG16L1 was detected with anti-ATG16L1 antibody (15 nm), and cholera toxin was detected using anti-HRP antibody. Scale bar, 150 nm.\
(B) HeLa cells were transiently transfected with GFP-ATG16L1 for 20 hr. Cells in basal conditions were fixed and labeled with anti-RAB11 antibody.\
(C) HeLa cells transfected with mStrawberry-ATG16L1 (20 hr) and starved (4 hr) were processed for immunogold labeling on cryosections. Double labeling was performed with rabbit anti-ATG16L1 (10 nm gold) and rabbit anti-RAB11 (15 nm gold). Scale bar, 150 nm. Schematic diagram shows membrane outlines from EM. Green lines indicate structures positive for both ATG16L1 and RAB11, whereas red lines are only positive for RAB11. Histogram shows the percentage by EM of ATG16L1 tubulovesicular structures that carry RAB11. 281 tubulovesiclular structures from different experiments were analyzed. Error bars, SD.\
(D) HeLa cells were transfected with EGFP-ATG16L1 and mCherry-RAB11, and 5 min movies were recorded. Representative images from movies are shown.\
(E) HeLa cells were loaded with mouse anti-transferrin receptor antibody (5E9C11) for 30 min and fixed for immunogold labeling for cryosections. The sample was labeled with rabbit anti-mouse antibody to recognize transferrin receptor (5 nm), anti-ATGL116 (10 nm), and anti-mATG9 (15 nm). Scale bar, 150 nm.\
(F) HeLa cells were transfected with pmStrawberry-ATG16L1 and ATG9L1-pEGFP, and 5 min movies were recorded. Representative images from the movies are shown.\
(G) HeLa cells were transfected with pmStrawberry-ATG16L1 and pEGFP-LC3, starved for 2 hr, fixed, and labeled for mATG9.\
See also [Figure S2](#figs2){ref-type="fig"} and [Movies S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc2){ref-type="supplementary-material"}.](gr2){#fig2}

![mATG9 and ATG16L1 Meet in Recycling Endosomes\
(A and B) (A) HeLa cells were incubated for 4 hr at 37°C or 18°C and processed for LC3II western blot. Some cells were incubated overnight with 20 mM NH~4~Cl in full medium (to block lysosomal degradation) at 37°C or 18°C (B).\
(C) HeLa cells were transfected with pEGFP-LC3 for 20 hr and incubated for 4 hr at 37°C or 18°C.\
(D and E) (D) HeLa cells were transfected with pEGFP-ATG16L1 for 20 hr and incubated for 4 hr at 37°C or 18°C. The size and the number (E) of vesicles were scored (a minimum of 20 cells were examined for each condition). Error bar, SEM. ^∗∗∗^p \< 0.001 and ^∗∗^p \< 0.01.\
(F and G) (F) HeLa cells were transfected with pEGFP-ATG16L1 for 20 hr, incubated for 4 hr at 37°C or 18°C, and labeled with EEA1 or RAB11 to visualize early endosomes or recycling endosomes. Histogram in (G) shows the amount of colocalization of ATG16L1 in EEA1 or in RAB11 compartment (Manders' coefficient). Error bar, SEM. NS, not significant; ^∗∗^p \< 0.01.\
(H) HeLa cells were transfected with pmStrawberry-ATG16L1 for 20 hr, fixed, and labeled for mATG9. The histograms show quantification of colocalization and the size of the vesicles labeled with ATG16L1 and mATG9 at 37°C or 18°C. Error bar, SEM. ^∗∗∗^p \< 0.001 and ^∗∗^p \< 0.01.\
(I) HeLa cells were transfected with pEGFP-RAB11 or pEGFP-Myosin Vb tail (MVb) and incubated during the last 16 hr with Bafilomycin A~1~ (Baf) or DMSO and processed for LC3-II western blot. Control cells were transfected with pEGFP empty vector.\
(J) HeLa cells were transfected with ATG16L1-mStrawberry and RAB11-EGFP or MVb tail-EGFP. The size of ATG16L1 vesicles was scored in RAB11 and MVb tail overexpression conditions. The inserts show just the ATG16L1 vesicles as quantified in histogram. Error bar, SEM. ^∗∗∗^p\<0.001.\
(K) HeLa cells were transfected as in (C) and loaded with transferrin Alexa-647 for 30 min. Histogram and the inserts show the correlation between ATG16L1 and the loaded transferrin (Pearson's coefficient). Error bar, SEM. ^∗∗∗^p \< 0.001.\
(L) HeLa cells were transfected as in (C) and labeled for mATG9. Histogram and the inserts show the correlation between ATG16L1 and mATG9 in RAB11 and MVb tail overexpression conditions (Pearson's coefficient). Error bar, SEM. ^∗∗∗^p \< 0.001.\
(M) HeLa cells were transfected with mStrawberry-ATG16L1 for 20 hr, starved in HBSS for 4 hr, or maintained in full medium, loaded with transferrin Alexa-488 (Tf). Pictures and histogram show the correlation between ATG16L1 and transferrin in basal and starving condition (Pearson's coefficient). Error bar, SEM. ^∗∗∗^p \< 0.001.\
(N) HeLa cells were transfected with mStrawberry-ATG16L1 for 20 hr, starved in HBSS for 4 hr, or maintained in full medium and then fixed and labeled with anti-mATG9 antibody. Pictures and histogram show the correlation between ATG16L1 and mATG9 in basal and starved cells (Pearson's coefficient). Error bar, SEM. ^∗∗∗^p \< 0.001.\
See also [Figure S3](#figs3){ref-type="fig"} and [Movies S3](#mmc3){ref-type="supplementary-material"} and [S4](#mmc4){ref-type="supplementary-material"}.](gr3){#fig3}

![mATG9/ATG16L1 Vesicle Fusion Is SNARE Dependent\
(A) HeLa cells were transfected with mStrawberry-ATG16 for 20 hr and treated for 10 min with N-ethylmaleimide (NEM; 100 μM) in full medium, fixed, and stained for mATG9. Histogram shows correlation between mATG9 and ATG16L1 (Pearson's coefficient). Error bar, SEM. ^∗∗∗^p \< 0.001.\
(B) Schematic diagram of the in vitro fusion assay of ATG16L1 and mATG9 vesicles. Postnuclear supernatants (PNS) of cells expressing mStrawberry-ATG16L1 were mixed with PNS from cells expressing ATG9L1-GFP for 1 hr in the presence of ATP, ATP and NEM at 37°C, or with ATP on ice. The samples were fixed and mounted on a microscope slide with Mowiol 4-88 for confocal analysis.\
(C and D) (C) Representative fields of in vitro fusion assay of ATG16L1 and mATG9 vesicles. The quantification in (D) was performed on ten fields (similar to that shown in the figure) per experiment. The quantification is expressed as Pearson's coefficient. Error bar, SEM. ^∗∗^p \< 0.001.](gr4){#fig4}

![VAMP3 Regulates Autophagy\
(A) HeLa cells were transfected with siRNAs for different R-SNAREs, and we assessed the levels of the autophagy substrate p62 versus actin.\
(B) HeLa cells transfected with control or VAMP3 siRNA (oligo A) for 4 days were treated during the last 16 hr with Bafilomycin A1 (Baf A1) or DMSO (basal) and processed for LC3-II western blots.\
(C) Endogenous LC3 immunocytochemistry in HeLa cells transfected with control or VAMP3 siRNA for 4 days. The histogram shows the number of vesicles (LC3 positive) in a minimum of 30 cells. Error bar, SEM. ^∗∗∗^p \< 0.001.\
(D) HeLa cells were transfected with VAMP3-HA for 20 hr and stained for EEA1 or RAB11. Histogram shows colocalization between VAMP3-HA and EEA1 or VAMP3-HA and RAB11 (Manders' coefficient). Error bar, SEM.\
(E) HeLa cells were transfected for 20 hr with VAMP3-HA, incubated for 1 hr at 37°C or 18°C, fixed, and labeled for HA and mATG9. Histogram shows the percentage of colocalization between VAMP3 with mATG9 (Manders' coefficient). Error bar, SEM. NS, not significant.\
See also [Figure S4](#figs4){ref-type="fig"}.](gr5){#fig5}

![VAMP3 Regulates mATG9 and ATG16L1 Trafficking\
(A--C) HeLa cells transfected with control, VAMP3 siRNA for 4 days were transfected during the last 20 hr with ATG9L1-pEGFP and labeled with anti-EEA1 (for early endosomes) or anti-RAB11 (for recycling endosomes). The histogram in (C) shows the quantification of the colocalization of mATG9 in EEA1 or RAB11 (Manders' coefficient). Error bars, SEM. ^∗∗∗^p \< 0.001.\
(D--F) HeLa cells were treated as in (A)--(C) and transfected during the last 20 hr with pEGFP-ATG16L1 and labeled with anti-EEA1 (early endosomes) or anti-RAB11 (recycling endosomes). Histogram in (D) shows quantification of the colocalization of ATG16L1 in EEA1 or RAB11 (Manders' coefficient). Error bars, SEM. ^∗∗∗^p \< 0.001; NS, not significant.](gr6){#fig6}

![VAMP3 Is Required for Fusion of Vesicles Carrying mATG9 and ATG16L1\
(A) HeLa cells transfected with control, VAMP3 siRNA for 4 days were transfected during the last 20 hr with mStrawberry-ATG16L1 and labeled for mATG9. The correlation between mATG9 and ATG16L1 was quantified (Pearson's coefficient). Error bar, SEM. ^∗∗∗^p \< 0.001.\
(B) HeLa cells were transfected with control or VAMP3 siRNA and then with mStrawberry-ATG16, and 5 min movies were recorded. Homotypic fusion events between mStrawberry-ATG16 vesicles were assessed in control and VAMP3 knockdown cells. Error bar, SEM. NS, not significant.\
(C) In vitro fusion assay of ATG16L1 and mATG9 vesicles. HeLa cells were transfected with control or VAMP3 siRNA for 4 days separately and, on the fourth day, either transfected with mStrawberry-ATG16L1 or ATG9L1-pEGFP. PNS of cells expressing the two constructs were mixed for 1 hr at 37C° and observed by confocal microscopy. Histogram shows the correlation of vesicles carrying ATG16L1 that fuse with vesicles carrying mATG9 (Pearson's coefficient). Error bar, SEM. ^∗∗∗^p \< 0.001. The total number of structures per field (ATG16L1 and ATG9L1) is not significantly different in the control and KD samples (control, 37 ± 3; VAMP3 KD, 45 ± 3; ± SEM; p = 0.106).\
(D) Schematic diagram of mATG9 and ATG16L1 itineraries pertinent to their heterotypic fusion and autophagosome formation.\
See also [Figure S5](#figs5){ref-type="fig"} and [Movies S5](#mmc5){ref-type="supplementary-material"} and [S6](#mmc6){ref-type="supplementary-material"}.](gr7){#fig7}

![mATG9 Is Trafficked from the Plasma Membrane to Early Endosomes, Related to [Figure 1](#fig1){ref-type="fig"}\
(A) HeLa cells were incubated 1 hr at 18°C or 37°C and loaded for 1h with transferrin Alexa-555. The pictures represent representative fields of transferrin localization at 18°C or 37°C. Transferrin localization appears more disperse at 18°C.\
(B) HeLa cells treated with the same protocol described in (A) were fixed and labeled with anti-EEA1 antibody (early endosome marker). At 18°C transferrin accumulates in early endosomes. The Pearson's Coefficient between transferrin and EEA1 was quantified in the histogram. Error Bar = SEM. ^∗∗∗^ = p \< 0.001.\
(C and C′) HeLa cells treated as in (A) were labeled with anti-RAB11 antibody -- RAB11 is the most commonly used marker for recycling endosomes. At 18°C transferrin is no longer able to reach the recycling endosome and therefore shows less colocalization with RAB11. The Pearson's Coefficient between transferrin and RAB11 was quantified in the histogram. Error Bar = SEM. ^∗∗∗^ = p \< 0.001.\
(D and D′) HeLa cells treated as in (A) were transfected with ATG9L1-GFP and labeled with anti-EEA1- EEA1 is the most commonly used marker for early endosomes. At 18°C mATG9 is no longer able to exit from the endosome and therefore shows more colocalization with EEA1. The Pearson's Coefficient between mATG9 and EEA1 was measured in the histogram. Error Bar = SEM. ^∗∗∗^ = p \< 0.001.\
(E) HeLa cells were transfected with dynamin dominant-negative mutant (K44A) for 20 hr, loaded for 30 min with transferrin Alexa-555 and labeled for mATG9. The pictures show a re-localization of mATG9 from perinuclear locations to a more peripheral area of the cell (close to plasma membrane).\
(F and G) HeLa cells were RNA silenced for AP2 (μ2) for 5 days to inhibit clathrin-mediated endocytosis and treated as in (E). A control blot shows the level of AP2 (μ2) reduction (the arrow shows the AP2 (μ2) band).\
(H) HeLa cells transfected or not with empty pEGFP vector were processed for immunogold labeling on cryosections and labeled with anti-ATG9 antibody. The GFP protein is cytoplasmic and is not associated with clathrin-coated structures. This marker was used as negative control for the specificity of mATG9 localization on clathrin-coated structures. Error bar = SEM.\
(I) HeLa cells were fixed in basal conditions and processed for immunogold labeling on cryosections and stained with anti-mATG9 antibody. 10 cell profiles in two different experiments were considered by counting the number of gold particles (mATG9) in different compartments (PM: plasma membrane; CCS: clathrin-coated structures; END: endosomes; AS: autophagic structures; GOLGI: Golgi). The percentage of mATG9 localization in different compartments was quantified in the histogram and expressed as percentage of the total. Error bar = SEM.\
(J) The histogram shows the quantification expressed as Pearson's Coefficient of the experiment shown in [Figure 1](#fig1){ref-type="fig"} G. Error bar = SEM. ^∗∗∗^ = p \< 0.001.\
(K) HeLa cells were fixed and labeled with EEA1 (early endosomes) and ATG16L1or mATG9. The Pearson's Coefficient between EEA1 and ATG16L1 or mATG9 was quantified in the histogram. Error bar = SEM. ^∗∗∗^ = p \< 0.001.\
(L) HeLa cells were transfected with GFP-RAB5 constitutively-active mutant (Q79L) for 20 hr and mStraw-ATG16L1, or transfected with GFP-RAB5 Q79L and labeled with anti-mATG9 antibody. This constitutively-active mutant induces aberrant fusion of early endosomes. The Pearson's Coefficient between RAB5 Q79L and mATG9 or ATG16L1 was quantified in the histogram. Error bar = SEM. ^∗∗∗^ = p \< 0.001.](figs1){#figs1}

![ATG12 and ATG16L1 Localize in Recycling Endosomes, Related to [Figure 2](#fig2){ref-type="fig"}\
(A) HeLa cells where transfected with GFP-RAB11 and labeled for ATG12 (the pictures show pseudo-colors). The amount of colocalization of ATG12 with RAB11 (recycling endosomes) is shown in the histogram expressed as Manders' Coefficient. Error bar = SEM.\
(B) HeLa cells were transfected with pmStrawberry-ATG16L1 and pEGFP-RAB11. 20 hr later, the cells were fixed in basal conditions and stained for mATG9. The histogram shows the relative colocalization between RAB11-ATG16L1, RAB11-mATG9 and ATG16L1-mATG9 expressed as Manders' Coefficient. Error bars = SEM.](figs2){#figs2}

![Recycling Endosome Trafficking Regulates ATG16L1/mATG9 Vesicle Fusion, Related to [Figure 3](#fig3){ref-type="fig"}\
(A) This figure shows the individual channels used for the composites in [Figure 3](#fig3){ref-type="fig"}H.\
(B) HeLa cells were transfected with HA-Q74 huntingtin and RAB11-EGFP or MVb tail-EGFP or EGFP empty vector constructs for 48 hr. The Q74 huntingtin aggregates were identified with anti-HA antibody. Error bar = SD from 3 different experiments. ^∗∗∗^ = p \< 0.001; ^∗∗^ = p \< 0.01.\
(C--E) This figure shows the individual channels (in negative to enable clear visualization of the vesicles) used for the composites in [Figures 3](#fig3){ref-type="fig"}J--3L.\
(F--G) HeLa cells were transfected with mCherry-RAB11 and pEGFP-ATG16L1 (F) or mStrawberry-ATG16L1 and EGFP-MVb tail (G). 5 movies of 5 min each movies were recorded each experiment. The histograms in F and G show the interactions (short and long-lived homotypic fusions) between ATG16L1 vesicles in control or RAB11- or MVb-overexpressing conditions. Error Bar = SEM. ^∗∗∗^ = p \< 0.001.\
(H) HeLa cells were amino acid- and serum-starved for 4 hr (or maintained in full medium) and loaded for 30 min with transferrin Alexa-647. Unlabeled transferrin was then used to induce recycling for different times. The samples were then fixed wit 4% Paraformaldehyde and analyzed by FACS. The values in the graph represent the amounts of intracellular Tf---higher values correspond to less recycling. Error Bar = SD. Post hoc Test Anova \< 0.05.\
(I) HeLa cells were transfected with pEGFP-ATG16L1. 5 movies of 5 min each were recorded in cells incubated with HBSS (starvation) or full medium. The histogram shows the homotypic interactions between ATG16L1 vesicles in control or starved cells. A minimum of 20 cells were examined each condition. Error Bar = SEM. ^∗∗∗^ = p \< 0.001. See also [Movies S3](#mmc3){ref-type="supplementary-material"} and [S4](#mmc4){ref-type="supplementary-material"}.](figs3){#figs3}

![VAMP3 Depletion Affects Autophagy and Does Not Affect General Endocytosis, Related to [Figure 5](#fig5){ref-type="fig"}\
(A) HeLa cells were transfected with oligos B (GGAUUACUGUUUCUGGUUAU) and C (GAGUUAACGUGGACAAGGU) for VAMP3, or with control oligo and blotted for LC3-II in presence (Baf A~1~) or absence of Bafilimycin A~1~ (basal). Tubulin was used as loading control.\
(B) HeLa cells transfected with control or VAMP3 siRNA (oligo A) for 4 days were subjected to immunocytochemistry for endogenous LC3.\
(C) HeLa cells were transfected for 20h with VAMP3-HA incubated 1 hr at 18°C or 37°C and labeled for endogenous ATG16L1. The colocalization at 18°C or 37°C is shown in [Figure 5](#fig5){ref-type="fig"}F.\
(D) HeLa cells transfected with control or VAMP3 siRNA were labeled for endogenous RAB11. E) HeLa cells treated with control or VAMP3 siRNA were loaded with transferrin Alexa-647 for different times (0, 2, 5, 10 and 15 min) or loaded for 30 min with transferrin Alexa-647, washed and incubated for different times (5, 10, 15 and 30 min) with unlabeled transferrin for the recycling assay. Error bar = SD. Loss of VAMP3 does not affect both transferrin uptake and recycling.](figs4){#figs4}

![VAMP3 Depletion Affects ATG16L1/mATG9 Vesicle Fusion, Related to [Figure 7](#fig7){ref-type="fig"}\
(A and B) HeLa cells transfected with control (A), VAMP3 siRNA (B) for 4 days were transfected for 20 hr with mStrawberry-ATG16L1 and ATG9L1-pEGFP. Representative images from 5 min Movies are shown. (See also [Movies S5](#mmc5){ref-type="supplementary-material"} and [S6](#mmc6){ref-type="supplementary-material"}.)](figs5){#figs5}
